Treatment of chronic mucocutaneous candidiasis has included drugs, immunotherapy, and replacement of nutritional and endocrine deficiency. Although amphotericin B is the best known and most commonly used form of treatment, the imidazole antibiotic clotrimazole has shown promise as an effective agent that can be given orally with low toxicity. A 9-year-old girl responded to intermittent clotrimazole therapy with complete and prolonged remission. This form of treatment offers advantages in safety and effectiveness over other therapies for chronic mucocutaneous candidiasis.
(Arch Dermatol 115:322-323, 1979)
Rockoff AS. Chronic Mucocutaneous Candidiasis: Successful Treatment With Intermittent Oral Doses of Clotrimazole. Arch Dermatol. 1979;115(3):322–323. doi:10.1001/archderm.1979.04010030030011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: